Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ceri E. Oldreive, Philip J. Byrd, Grant S. Stewart, Alexander J. Taylor, Sana Farhat, Anna Skowronska, Edward Smith, Manoj Raghavan, Dragana Janic, Lidija Dokmanovic, Sam Clokie, Nicholas Davies, Marwan Kwok, Guy Pratt, Shankara Paneesha, Paul Moss, Tatjana Stankovic & Malcolm Taylor. (2019) PALB2 variant status in hematological malignancies – a potential therapeutic target?. Leukemia & Lymphoma 60:7, pages 1823-1826.
Read now
Read now
Eiji Kubota, Christopher T Williamson, Ruiqiong Ye, Anifat Elegbede, Lars Peterson, Susan P Lees-Miller & D Gwyn Bebb. (2014) Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines. Cell Cycle 13:13, pages 2129-2137.
Read now
Read now
Gerard Lozanski, Amy S. Ruppert, Nyla A. Heerema, Arletta Lozanski, David M. Lucas, Amber Gordon, John G. Gribben, Vicki A. Morrison, Kanti M. Rai, Guido Marcucci, Richard A. Larson & John C. Byrd. (2012) Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study. Leukemia & Lymphoma 53:9, pages 1743-1748.
Read now
Read now
Xiaojun Liu, Hagop Kantarjian & William Plunkett. (2012)
Sapacitabine for cancer. Expert Opinion on Investigational Drugs 21:4, pages 541-555.
Read now
Read now
John D. Dickinson, Jamie Gilmore, Javeed Iqbal, Warren Sanger, James C. Lynch, John Chan, Philip J. Bierman & Shantaram S. Joshi. (2006) 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules. Leukemia & Lymphoma 47:2, pages 231-244.
Read now
Read now
Articles from other publishers (64)
Juan-Manuel Hernandez-Martinez, Rafael Rosell & Oscar Arrieta. (2023) Somatic and germline ATM variants in non-small-cell lung cancer: Therapeutic implications. Critical Reviews in Oncology/Hematology 188, pages 104058.
Crossref
Crossref
Xiao Jiang, Amanda O'Neill, Katherine R. Smith, Zhongwu Lai, Keren Carss, Quanli Wang & Slavé Petrovski. (2022)
Uncovering variable neoplasms between
ATM
protein‐truncating and common missense variants using 394 694
UK
Biobank exomes
. Genes, Chromosomes and Cancer 61:9, pages 523-529.
Crossref
Crossref
Panruo Jiang, Aakash Desai & Haige Ye. (2021) Progress in molecular feature of smoldering mantle cell lymphoma. Experimental Hematology & Oncology 10:1.
Crossref
Crossref
Veronica Ortega, Christina Mendiola, Juana Rodriguez, William EhmanJr.Jr., You-Wen Qian & Gopalrao Velagaleti. (2021) Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?. Molecular Cytogenetics 14:1.
Crossref
Crossref
Sabrina Putti, Alessandro Giovinazzo, Matilde Merolle, Maria Laura Falchetti & Manuela Pellegrini. (2021) ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer. Cancers 13:21, pages 5498.
Crossref
Crossref
Sang-Yong Shin, Hyeonah Lee, Seung-Tae Lee, Jong Rak Choi, Chul Won Jung, Hong Hoe Koo & Sun-Hee Kim. (2021) Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients. Scientific Reports 11:1.
Crossref
Crossref
Kavita Bhalla, Sausan Jaber, Kayla Reagan, Arielle Hamburg, Karen F. Underwood, Aditya Jhajharia, Maninder Singh, Binny Bhandary, Shambhu Bhat, Nahid M. Nanaji, Ruching Hisa, Carrie McCracken, Heather Huot Creasy, Rena G. Lapidus, Tami Kingsbury, Dirk Mayer, Brian Polster & Ronald B. Gartenhaus. (2020) SIRT3, a metabolic target linked to ataxia-telangiectasia mutated (ATM) gene deficiency in diffuse large B-cell lymphoma. Scientific Reports 10:1.
Crossref
Crossref
Alejandro Álvarez-Quilón, José Terrón-Bautista, Irene Delgado-Sainz, Almudena Serrano-Benítez, Rocío Romero-Granados, Pedro Manuel Martínez-García, Silvia Jimeno-González, Cristina Bernal-Lozano, Cristina Quintero, Lourdes García-Quintanilla & Felipe Cortés-Ledesma. (2020) Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency. Nature Communications 11:1.
Crossref
Crossref
M. Cross & C. Dearden. (2019) B and T cell prolymphocytic leukaemia. Best Practice & Research Clinical Haematology 32:3, pages 217-228.
Crossref
Crossref
Isabella Faraoni, Manuela Giansanti, Maria Teresa Voso, Francesco Lo-Coco & Grazia Graziani. (2019) Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders. Biochemical Pharmacology 167, pages 133-148.
Crossref
Crossref
Rajib Ghosh, Debamitra Das & Sonia Franco. 2018. Chromosome Translocation. Chromosome Translocation
65
87
.
Masatoshi Takagi, Misa Yoshida, Yoshino Nemoto, Hiroyuki Tamaichi, Rika Tsuchida, Masafumi Seki, Kumiko Uryu, Noriko Hoshino, Rina Nishii, Satoshi Miyamoto, Masahiro Saito, Toshiaki Shimizu, Ryoji Hanada, Hideo Kaneko, Toshiyuki Fukao, Takatoshi Koyama, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Yusuke Sato, Yoichi Fujii, Keisuke Kataoka, Yusuke Okuno, Kenichi Yoshida, Tomohiro Morio, Akira Oka, Miki Ohira, Yasuhide Hayashi, Akira Nakagawara, Seishi Ogawa, Shuki Mizutani & Junko Takita. (2017) Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor. JNCI: Journal of the National Cancer Institute 109:11.
Crossref
Crossref
Chen Wang, Nicholas Jette, Daniel Moussienko, D. Gwyn Bebb & Susan P. Lees-Miller. (2017) ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib. Translational Oncology 10:2, pages 190-196.
Crossref
Crossref
Ling Li, Tao Zhu, Yuan-Feng Gao, Wei Zheng, Chen-Jing Wang, Ling Xiao, Ma-Sha Huang, Ji-Ye Yin, Hong-Hao Zhou & Zhao-Qian Liu. (2016) Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer. International Journal of Molecular Sciences 17:6, pages 839.
Crossref
Crossref
Marila Cordeiro‐Stone, John J. McNulty, Christopher D. Sproul, Paul D. Chastain, Eugene Gibbs‐Flournoy, Yingchun Zhou, Craig Carson, Shangbang Rao, David L. Mitchell, Dennis A. Simpson, Nancy E. Thomas, Joseph G. Ibrahim & William K. Kaufmann. (2015) Effective intra‐S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines. Pigment Cell & Melanoma Research 29:1, pages 68-80.
Crossref
Crossref
Wynand P. Roos, Adam D. Thomas & Bernd Kaina. (2015) DNA damage and the balance between survival and death in cancer biology. Nature Reviews Cancer 16:1, pages 20-33.
Crossref
Crossref
Frank P. Vendetti, Alan Lau, Sandra Schamus, Thomas P. Conrads, Mark J. O’Connor & Christopher J. Bakkenist. (2015)
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer
in vivo
. Oncotarget 6:42, pages 44289-44305.
Crossref
Crossref
Karen S. HathcockHesed M. Padilla-NashJordi CampsDong-Mi ShinDaniel TrinerArthur L. ShafferIIIIII, Robert W. MaulSeth M. Steinberg, Patricia J. Gearhart, Louis M. StaudtHerbert C. MorseIIIIII, Thomas RiedRichard J. Hodes. (2015) ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans. Blood 126:20, pages 2291-2301.
Crossref
Crossref
Jana Prochazkova, Shinya Sakaguchi, Michel Owusu, Abdelghani Mazouzi, Marc Wiedner, Georgia Velimezi, Martin Moder, Gleb Turchinovich, Anastasiya Hladik, Elisabeth Gurnhofer, Adrian Hayday, Axel Behrens, Sylvia Knapp, Lukas Kenner, Wilfried Ellmeier & Joanna I. Loizou. (2015) DNA Repair Cofactors ATMIN and NBS1 Are Required to Suppress T Cell Activation. PLOS Genetics 11:11, pages e1005645.
Crossref
Crossref
Haley M. Simpson, Rashid Z. Khan, Chang Song, Deva Sharma, Kavitha Sadashivaiah, Aki Furusawa, Xinyue Liu, Sushma Nagaraj, Naomi Sengamalay, Lisa Sadzewicz, Luke J. Tallon, Qing C. Chen, Ferenc Livak, Aaron P. Rapoport, Amy Kimball & Arnob Banerjee. (2015) Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma. PLOS ONE 10:11, pages e0141906.
Crossref
Crossref
Wenxia JiangBrian J. LeeChen LiRichard L. DuboisMonica Gostissa, Frederick W. Alt & Shan Zha. (2015) Aberrant TCRδ rearrangement underlies the T-cell lymphocytopenia and t(12;14) translocation associated with ATM deficiency. Blood 125:17, pages 2665-2668.
Crossref
Crossref
Jennifer A. Bennett & Michael G. Bayerl. (2015) Epstein-Barr Virus–associated Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue (MALT Lymphoma) Arising in the Parotid Gland of a Child With Ataxia Telangiectasia. Journal of Pediatric Hematology/Oncology 37:2, pages e114-e117.
Crossref
Crossref
Andy C. Hsi, Diane H. Robirds, Jingqin Luo, Friederike H. Kreisel, John L. Frater & TuDung T. Nguyen. (2014) T-cell Prolymphocytic Leukemia Frequently Shows Cutaneous Involvement and Is Associated With Gains of MYC, Loss of ATM, and TCL1A Rearrangement. American Journal of Surgical Pathology 38:11, pages 1468-1483.
Crossref
Crossref
Xuesong Li, Nigel J O’Neil, Noushin Moshgabadi & Philip Hieter. (2014) Synthetic Cytotoxicity: Digenic Interactions with TEL1/ATM Mutations Reveal Sensitivity to Low Doses of Camptothecin. Genetics 197:2, pages 611-623.
Crossref
Crossref
Ian Maze, Kyung-Min Noh, Alexey A. Soshnev & C. David Allis. (2014) Every amino acid matters: essential contributions of histone variants to mammalian development and disease. Nature Reviews Genetics 15:4, pages 259-271.
Crossref
Crossref
Chiara Vardabasso, Dan Hasson, Kajan Ratnakumar, Chi-Yeh Chung, Luis F. Duarte & Emily Bernstein. (2013) Histone variants: emerging players in cancer biology. Cellular and Molecular Life Sciences 71:3, pages 379-404.
Crossref
Crossref
Enea Gino Di Domenico, Elena Romano, Paola Del Porto & Fiorentina Ascenzioni. (2014) Multifunctional Role of ATM/Tel1 Kinase in Genome Stability: From the DNA Damage Response to Telomere Maintenance. BioMed Research International 2014, pages 1-17.
Crossref
Crossref
Yosef Shiloh. 2015. Molecular Oncology. Molecular Oncology
403
422
.
Peter J. McKinnon. (2012) ATM and the Molecular Pathogenesis of Ataxia Telangiectasia. Annual Review of Pathology: Mechanisms of Disease 7:1, pages 303-321.
Crossref
Crossref
Heather L. Armata, Punita Shroff, David E. Garlick, Krista Penta, Andrew R. Tapper & Hayla K. Sluss. (2011) Loss of p53 Ser18 and Atm Results in Embryonic Lethality without Cooperation in Tumorigenesis. PLoS ONE 6:9, pages e24813.
Crossref
Crossref
Kimberly Vanhees, Laura de Bock, Roger W. L. Godschalk, Frederik J. van Schooten & Sahar Barjesteh van Waalwijk van Doorn-Khosrovani. (2011) Prenatal Exposure to Flavonoids: Implication for Cancer Risk. Toxicological Sciences 120:1, pages 59-67.
Crossref
Crossref
Victoria J. WestonCeri E. OldreiveAnna SkowronskaDavid G. OscierGuy PrattMartin J. S. DyerGraeme SmithJudy E. Powell, Zbigniew Rudzki, Pamela KearnsPaul A. H. MossA. Malcolm R. TaylorTatjana Stankovic. (2010) The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood 116:22, pages 4578-4587.
Crossref
Crossref
Angela Poehlmann & Albert Roessner. (2010) Importance of DNA damage checkpoints in the pathogenesis of human cancers. Pathology - Research and Practice 206:9, pages 591-601.
Crossref
Crossref
Frederick G. Behm. 2010. Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology of Hematolymphoid Diseases
21
64
.
L. P. G. D’Arce, C. L. Bassi, A. L. Fachin, G. A. S. Passos & E. T. Sakamoto-Hojo. (2009) Occurrence of TRGV-BJ hybrid gene in SV40-transformed fibroblast cell lines. Genetica 136:3, pages 471-478.
Crossref
Crossref
M Honda, M Takagi, L Chessa, T Morio & S Mizuatni. (2008) Rapid diagnosis of ataxia-telangiectasia by flow cytometric monitoring of DNA damage-dependent ATM phosphorylation. Leukemia 23:2, pages 409-414.
Crossref
Crossref
Emilie Le Toriellec, Gilles Despouy, Gaëlle Pierron, Nogaye Gaye, Marjorie Joiner, Dorine Bellanger, Anne Vincent-Salomon & Marc-Henri Stern. (2008) Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia. Blood 111:4, pages 2321-2328.
Crossref
Crossref
Bin Kang, Rui-Fang Guo, Xiao-Hui Tan, Min Zhao, Zhuo-Bin Tang & You-Yong Lu. (2008) Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 638:1-2, pages 17-25.
Crossref
Crossref
Payal Sipahimalani, John J. Spinelli, Amy C. MacArthur, Agnes Lai, Stephen R. Leach, Rozmin T. Janoo‐Gilani, Diana L. Palmquist, Joseph M. Connors, Randy D. Gascoyne, Richard P. Gallagher & Angela R. Brooks‐Wilson. (2007)
A systematic evaluation of the
ataxia telangiectasia mutated
gene does not show an association with non‐Hodgkin lymphoma
. International Journal of Cancer 121:9, pages 1967-1975.
Crossref
Crossref
Richard J. FordLong ShenYen Chiu Lin-LeeLan V. PhamAsha MultaniHai-Jun ZhouArchito T. TamayoChongJie ZhangLesleyann Hawthorn, John K. Cowell & Julian L. AmbrusJrJr. (2007) Development of a murine model for blastoid variant mantle-cell lymphoma. Blood 109:11, pages 4899-4906.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Penny A. Jeggo & Markus Löbrich. (2006) Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of genomic stability. DNA Repair 5:9-10, pages 1192-1198.
Crossref
Crossref
S Rashi-Elkeles, R Elkon, N Weizman, C Linhart, N Amariglio, G Sternberg, G Rechavi, A Barzilai, R Shamir & Y Shiloh. (2005) Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene 25:10, pages 1584-1592.
Crossref
Crossref
Krystyna H. Chrzanowska, Dorota Piekutowska-Abramczuk, Ewa Popowska, Małgorzata Gładkowska-Dura, Jadwiga Małdyk, Małgorzata Syczewska, Małgorzata Krajewska-Walasek, Bożenna Goryluk-Kozakiewicz, Halina Bubała, Artur Gadomski, Anna Gaworczyk, Bernarda Kazanowska, Andrzej Kołtan, Marta Kuźmicz, Teresa Luszawska-Kutrzeba, Lucyna Maciejka-Kapuścińska, Małgorzata Stolarska, Katarzyna Stefańska, Katarzyna Sznurkowska, Anna Wakulińska, Maria Wieczorek, Tomasz Szczepański & Jerzy Kowalczyk. (2006) Carrier frequency of mutation 657del5 in the NBS1 gene in a population of polish pediatric patients with sporadic lymphoid malignancies. International Journal of Cancer 118:5, pages 1269-1274.
Crossref
Crossref
Timothy C. GreinerChiranjib DasguptaVincent V. HoDennis D. WeisenburgerLynette M. SmithJames C. LynchJulie M. VoseKai FuJames O. ArmitageRita M. BrazielElias CampoJan DelabieRandy D. GascoyneElaine S. Jaffe, Hans K. Muller-Hermelink, German Ott, Andreas Rosenwald, Louis M. Staudt, Michael Y. ImMazen W. KaramanBrian L. PikeWing C. ChanJoseph G. Hacia. (2006)
Mutation and genomic deletion status of
ataxia telangiectasia mutated
(
ATM
) and
p53
confer specific gene expression profiles in mantle cell lymphoma
. Proceedings of the National Academy of Sciences 103:7, pages 2352-2357.
Crossref
Crossref
Irina R. Matei, Cynthia J. Guidos & Jayne S. Danska. (2006) ATM-dependent DNA damage surveillance in T-cell development and leukemogenesis: the DSB connection. Immunological Reviews 209:1, pages 142-158.
Crossref
Crossref
Sa Kan YOO, Nobuyuki ONISHI, Naoko KATO, Akinori YODA & Yasuhiro MINAMI. (2006) Relationship between abnormalities of genes involved in DNA damage responses and malignant tumors/autoimmune diseasesＤＮＡ損傷応答関連遺伝子の異常と悪性腫瘍・自己免疫疾患との関連について. Japanese Journal of Clinical Immunology 29:3, pages 136-147.
Crossref
Crossref
Gábor Méhes. (2005) Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia. Pathology & Oncology Research 11:4, pages 205-210.
Crossref
Crossref
Errol C. Friedberg, Graham C. Walker, Wolfram Siede, Richard D. Wood, Roger A. Schultz & Tom Ellenberger. 2005. DNA Repair and Mutagenesis. DNA Repair and Mutagenesis
919
946
.
Janet Hall. (2005) The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants. Cancer Letters 227:2, pages 105-114.
Crossref
Crossref
R Schmitz, C Renné, R Rosenquist, M Tinguely, V Distler, F Menestrina, M Lestani, T Stankovic, B Austen, A Bräuninger, M-L Hansmann & R Küppers. (2005) Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas. Leukemia 19:8, pages 1452-1458.
Crossref
Crossref
Ralf Küppers, Roland Schmitz, Verena Distler, Christoph Renné, Andreas Bräuninger & Martin-Leo Hansmann. (2005) Pathogenesis of Hodgkin's lymphoma. European Journal of Haematology 75, pages 26-33.
Crossref
Crossref
Virginie Lespinet, Fanny Terraz, Christian Recher, Elias Campo, Janet Hall, Georges Delsol & Talal Al Saati. (2005) Single-cell analysis of loss of heterozygosity at theATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma:ATM loss of heterozygosity is a rare event. International Journal of Cancer 114:6, pages 909-916.
Crossref
Crossref
Xianghong Kuang, Mingshan Yan, Na Liu, Virginia L. Scofield, Wenan Qiang, Jodi Cahill, Williams S. Lynn & Paul K. Y. Wong. (2004) Control of Atm?/? thymic lymphoma cell proliferation in vitro and in vivo by dexamethasone. Cancer Chemotherapy and Pharmacology 55:3, pages 203-212.
Crossref
Crossref
E. Cavaciuti, A. Laugé, N. Janin, K. Ossian, J. Hall, D. Stoppa-Lyonnet & N. Andrieu. (2005)
Cancer risk according to type and location of
ATM
mutation in ataxia-telangiectasia families
. Genes, Chromosomes and Cancer 42:1, pages 1-9.
Crossref
Crossref
Peter J McKinnon. (2004) ATM and ataxia telangiectasia. EMBO reports 5:8, pages 772-776.
Crossref
Crossref
Dragan Gamberger, Nada Lavrač, Filip Železný & Jakub Tolar. (2004) Induction of comprehensible models for gene expression datasets by subgroup discovery methodology. Journal of Biomedical Informatics 37:4, pages 269-284.
Crossref
Crossref
Oscar Fernandez-Capetillo, Alicia Lee, Michel Nussenzweig & André Nussenzweig. (2004) H2AX: the histone guardian of the genome. DNA Repair 3:8-9, pages 959-967.
Crossref
Crossref
Guanzhen Yu, Ming-hua Zhu, Zhi Zhu, Can-rong Ni, Jian-ming Zheng & Fang-mei Li. (2004) Expression of ATM Protein and Its Relationship With p53 in Pancreatic Carcinoma With Tissue Array. Pancreas 28:4, pages 421-426.
Crossref
Crossref
Megan S. Lim & Kojo S.J. Elenitoba-Johnson. (2004) The Molecular Pathology of Primary Immunodeficiencies. The Journal of Molecular Diagnostics 6:2, pages 59-83.
Crossref
Crossref
Suzanne J. Baker & Peter J. McKinnon. (2004) Tumour-suppressor function in the nervous system. Nature Reviews Cancer 4:3, pages 184-196.
Crossref
Crossref
Ella Liberzon, Smadar Avigad, Batia Stark, Julia Zilberstein, Laurence Freedman, Malka Gorfine, Herzel Gavriel, Ian J. Cohen, Yacov Goshen, Isaac Yaniv & Rina Zaizov. (2003)
Germ‐line
ATM
gene alterations are associated with susceptibility to sporadic T‐cell acute lymphoblastic leukemia in children
. Genes, Chromosomes and Cancer 39:2, pages 161-166.
Crossref
Crossref
Arkady Celeste, Simone Difilippantonio, Michael J. Difilippantonio, Oscar Fernandez-Capetillo, Duane R. Pilch, Olga A. Sedelnikova, Michael Eckhaus, Thomas Ried, William M. Bonner & André Nussenzweig. (2003) H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility. Cell 114:3, pages 371-383.
Crossref
Crossref
Yosef Shiloh. (2003) ATM and related protein kinases: safeguarding genome integrity. Nature Reviews Cancer 3:3, pages 155-168.
Crossref
Crossref